Results
1 -
10 of
57
(Click
here to explore results)
A genome -wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatments . Attila A. Seyhan, Usha Varadarajan, Sung Choe, Yan Liu, John McGraw, Matthew Woods, Stuart Murray, Amy Eckert, Wei Liu, Terence E. Ryan
, Mol. BioSyst.
, 2011
, 7
, 1974
A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers . Attila A. Seyhan, Usha Varadarajan, Sung Choe, Wei Liu, Terence E. Ryan
, Mol. BioSyst.
, 2012
, 8
, 1553
Effect of double mutations T790M/L858R on conformation and drug-resistant mechanism of epidermal growth factor receptor explored by molecular dynamics simulations . Fangfang Yan, Xinguo Liu, Shaolong Zhang, Jing Su, Qinggang Zhang, Jianzhong Chen
, RSC Adv.
, 2018
, 8
, 39797
Efficacy of tyrosine kinase inhibitors examined by a combination of Raman micro-spectroscopy and a deep wavelet scattering-based multivariate analysis framework . Irina Schuler, Martin Schuler, Tatjana Frick, Dairovys Jimenez, Abdelouahid Maghnouj, Stephan Hahn, Rami Zewail, Klaus Gerwert, Samir F. El-Mashtoly
, Analyst
, 2024
, 149
, 2004
Advances in covalent kinase inhibitors . Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, Richard Moriggl, Patrick T. Gunning
, Chem. Soc. Rev.
, 2020
, 49
, 2617
Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer . Amr Selim Abu Lila, Rohini Bhattacharya, Afrasim Moin, Turki Al Hagbani, Marwa Helmy Abdallah, Syed Mohd Danish Rizvi, El-Sayed Khafagy, Talib Hussain, Hosahalli Veerabhadrappa Gangadharappa
, RSC Adv.
, 2023
, 13
, 24309
Synthesis and evaluation of novel non-covalent binding quinazoline glycoside derivatives targeting the L858R and T790M variants of EGFR . Renshuai Zhang, Shaopeng Chen, Xiaowei Zhang, Rilei Yu, Shengbiao Wan, Meiyu Geng, Tao Jiang
, RSC Adv.
, 2016
, 6
, 36857
In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases . C. I. Wells, N. R. Kapadia, R. M. Couñago, D. H. Drewry
, Med. Chem. Commun.
, 2018
, 9
, 44
The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib . Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
, Org. Biomol. Chem.
, 2013
, 11
, 1766
Synthesis and biological evaluation of novel 2-morpholino-4-anilinoquinoline derivatives as antitumor agents against HepG2 cell line . Ahmed Al-Sheikh, Malak A. Jaber, Hana'a Khalaf, Nour AlKhawaja, Duaa Abuarqoub
, RSC Adv.
, 2024
, 14
, 3304